Mohammad S. Rostami

Array ( [id] => 7640143 [patent_doc_number] => 06395772 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Method for blocking endothelial cell-leukocyte attachment by inhibiting expression of adhesion molecules on the vascular endothelium for therapeutic applications' [patent_app_type] => B1 [patent_app_number] => 09/304415 [patent_app_country] => US [patent_app_date] => 1999-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 2221 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395772.pdf [firstpage_image] =>[orig_patent_app_number] => 09304415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534065 [patent_doc_number] => 06410792 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/294961 [patent_app_country] => US [patent_app_date] => 1999-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18990 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 682 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410792.pdf [firstpage_image] =>[orig_patent_app_number] => 09294961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272744 [patent_doc_number] => 06245817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'NPY5 receptor antagonists and methods for using same' [patent_app_type] => 1 [patent_app_number] => 9/295073 [patent_app_country] => US [patent_app_date] => 1999-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13317 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 732 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245817.pdf [firstpage_image] =>[orig_patent_app_number] => 295073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1457202 [patent_doc_number] => 06425881 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-30 [patent_title] => 'Therapeutic mixture useful in inhibiting lesion formation after vascular injury' [patent_app_type] => B1 [patent_app_number] => 09/293392 [patent_app_country] => US [patent_app_date] => 1999-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 14606 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/425/06425881.pdf [firstpage_image] =>[orig_patent_app_number] => 09293392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406399 [patent_doc_number] => 06271218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Method for inhibiting deoxyribonucleotide triphosphate biosynthesis' [patent_app_type] => 1 [patent_app_number] => 9/254652 [patent_app_country] => US [patent_app_date] => 1999-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3795 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271218.pdf [firstpage_image] =>[orig_patent_app_number] => 254652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470117 [patent_doc_number] => 06407058 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Modifying the permeability of physiological barriers' [patent_app_type] => B1 [patent_app_number] => 09/280593 [patent_app_country] => US [patent_app_date] => 1999-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 8273 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407058.pdf [firstpage_image] =>[orig_patent_app_number] => 09280593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586464 [patent_doc_number] => 06359009 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Substituted anilide insecticidal agents' [patent_app_type] => B1 [patent_app_number] => 09/277656 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7539 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359009.pdf [firstpage_image] =>[orig_patent_app_number] => 09277656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216524 [patent_doc_number] => 06110918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist' [patent_app_type] => 1 [patent_app_number] => 9/180456 [patent_app_country] => US [patent_app_date] => 1999-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3678 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110918.pdf [firstpage_image] =>[orig_patent_app_number] => 180456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237647 [patent_doc_number] => 06143753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Pharmaceutical composition for the treatment of malignant neoplasms and immunosuppressive deficiencies and its method of production' [patent_app_type] => 1 [patent_app_number] => 9/202126 [patent_app_country] => US [patent_app_date] => 1999-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1786 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143753.pdf [firstpage_image] =>[orig_patent_app_number] => 202126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418463 [patent_doc_number] => 06194395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Cyclodextrin cladribine formulations' [patent_app_type] => 1 [patent_app_number] => 9/257809 [patent_app_country] => US [patent_app_date] => 1999-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3402 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194395.pdf [firstpage_image] =>[orig_patent_app_number] => 257809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4307295 [patent_doc_number] => 06241981 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Composition and method for repairing neurological tissue' [patent_app_type] => 1 [patent_app_number] => 9/242628 [patent_app_country] => US [patent_app_date] => 1999-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8695 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/241/06241981.pdf [firstpage_image] =>[orig_patent_app_number] => 242628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410016 [patent_doc_number] => 06265421 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Phospholamban inhibitors and a method for increasing coronary flow' [patent_app_type] => 1 [patent_app_number] => 9/252062 [patent_app_country] => US [patent_app_date] => 1999-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 16958 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265421.pdf [firstpage_image] =>[orig_patent_app_number] => 252062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558976 [patent_doc_number] => RE037670 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Antiproliferative and neurotrophic molecules' [patent_app_type] => E1 [patent_app_number] => 09/250001 [patent_app_country] => US [patent_app_date] => 1999-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 8336 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037670.pdf [firstpage_image] =>[orig_patent_app_number] => 09250001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150723 [patent_doc_number] => 06770673 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'Therapeutic uses of arglabin in combination with other chemotherapy agents' [patent_app_type] => B1 [patent_app_number] => 09/241110 [patent_app_country] => US [patent_app_date] => 1999-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 15197 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770673.pdf [firstpage_image] =>[orig_patent_app_number] => 09241110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4350418 [patent_doc_number] => 06214843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Preventives and remedies for ischemic intestinal lesion and ileus' [patent_app_type] => 1 [patent_app_number] => 9/147169 [patent_app_country] => US [patent_app_date] => 1999-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9129 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214843.pdf [firstpage_image] =>[orig_patent_app_number] => 147169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4368200 [patent_doc_number] => 06274579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Pharmaceutically active morpholinol' [patent_app_type] => 1 [patent_app_number] => 9/233531 [patent_app_country] => US [patent_app_date] => 1999-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4531 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274579.pdf [firstpage_image] =>[orig_patent_app_number] => 233531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404085 [patent_doc_number] => 06171778 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Use of arabinogalactan in a sperm wash product' [patent_app_type] => 1 [patent_app_number] => 9/232269 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5429 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171778.pdf [firstpage_image] =>[orig_patent_app_number] => 232269 [rel_patent_id] =>[rel_patent_doc_number] =>)